Prophylaxis of thromboembolic events in congestive heart failure

Archives of Gerontology and Geriatrics

Volumn 23, Issue 3, 1996, Pages 329-336

  Di Pasquale, Giuseppe ^a   Passarelli, Paola ^a   Ribani, Maria Angela ^a   Borgatti, Maria Lucia ^a   Urbinati, Stefano ^a   Pinelli, Giuseppe ^a  

^a BELLARIA HOSPITAL   (Italy)

Author keywords

Anticoagulant therapy; Atrial fibrillation; Congestive heart failure; Left ventricular thrombus; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ANEURYSM; HEART VENTRICLE FUNCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; META ANALYSIS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOEMBOLISM;

THROMBUS;

EID: 0030294753     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(96)00728-5     Document Type: Article

References (29)

1. ASPECT Research Group (1994): Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet, 343, 499-503.
2. Baker, D.W. and Wright, R.F. (1994): Management of heart failure: anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. J. Am. Med. Assoc., 272, 1614-1618.
3. Cerebral Embolism Task Force (1989): Cardiogenic brain embolism. Arch. Neurol., 46, 727-743.
4. Ciaccheri, M., Castelli, Q., Cecchi, F., Nannini, M., Santoro, G., Troiani, V., Zuppiroli, A. and Dolara, A. (1989): Lack of correlation between intracavitary thrombosis detected by cross-sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. Br. Heart J., 62, 26-29.
5. Ciaccheri, M., Castelli, G., Nannini, M., Santoro, G., Troiani, V. and Dolara, A. (1995): Oral anticoagulant therapy in dilated cardiomyopathy. Results of treatment with warfarin in groups of patients at risk of embolic complications. G. Ital. Cardiol., 25, 689-694.
6. Cohn, J.N., Archibald, D.G., Ziesche, S., Franciosa, J.A., Harston, W.E., Tristam, F.E., Dunkman, W.B., Jacobs, W., Francis, G.S., Floher, K.H., Goldman, S., Cobb, F.R., Shah, P.M., Saunders, R., Fletcher, R.D., Loeb, H.S., Hughes, V.C. and Baker, B. (1986): Effect of vasodilator therapy on mortality in chronic congestive heart failure:results of a Veterans Administration Cooperative Study. N. Engl. J. Med., 314, 1547-1552.
7. Cohn, J.N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W.B., Lobb, H., Wong, M., Bhat, G., Goldman, S., Fletcher, R.D., Doherty, J., Hughes, C.V., Carson, P., Cintron, G., Shabetai, R. and Haakenson, C. (1991): A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med., 325, 303-310, 351-353.
8. Cohn, J.N., Benedict, C.R., LeJemtel, T.H., Grover, J., Shindler, D.M. and Shelton, B. (1992): Risk of thromboembolism in left ventricular dysfunction: SOLVD. Circulation, 86, (Suppl I) 1252.
9. CONSENSUS Trial Study Group (1987): Effects of enalapril on mortality in severe congestive heart failure. N. Engl. J. Med., 316, 1429-1435.
10. Dunkman, W.B., Johnson, G.R., Carson, P.E., Bhat, G., Farrell, L. and Cohn, J.N., for the V-HeFT VA Cooperative Studies Group (1993): Incidence of thromboembolic events in congestive heart failure. Circulation, 87, (Suppl VI) 94-101.
11. EAFT Study Group (1993): Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet, 342, 1255-1262.
12. Falk, R.H., Foster, E. and Coats, M.H. (1992): Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am. Heart. J., 123, 136-142.
13. Fuster, V., Gersh, B.J., Giuliani, E.R., Tajik, A.J., Brandenburg, R.O. and Frye, R.L. (1981): The natural history of idiopathic dilated cardiomyopathy. Am. J. Cardiol., 47, 525-531.
14. Gavazzi, A., Lanzarini, L., Cornalba, C., Desperati, M., Raisaro, A., Angoli, L., De Servi, S. and Specchia, G. (1984): Dilated (congestive) cardiomyopathy. Follow-up study of 137 patients. G. Ital. Cardiol., 14, 492-498.
15. Gottdiener, J.S., Gay, J.A., VanVoorhees, L., Di Bianco, R. and Flercher, R.D. (1983): Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. Am. J. Cardiol., 52, 1281-1285.
16. Hart, R.G., Boop, B.S. and Anderson, D.C. (1995): Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke, 26, 1471-1477.
17. Hinton, R.C., Kistler, C.P., Fallon, J.T., Friedlich, A.L. and Fischer, C.M. (1977): Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am. J. Cardiol., 40, 509-513.
18. Jafri, S.M., Osawa, T., Mammen, E., Levine, T.B., Johnson, C. and Goldstein, S. (1993): Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur. Heart J., 14, 205-212.
19. Katz, S.D., Marantz, P.R., Biasucci, L., Jondeau, G., Lee, K., Brennan, C.L. and Jemtel, T.H. (1993): Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Am. Heart J., ., 126, 141-146.
20. Kyrle, P., Korninger, C., Gossinger, H., Glogar, D., Lechner, K., Niessner, H. and Pabinger, I. (1985): Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb. Haemost., 54, 521-523.
21. Lapeyre III, A.C., Steele, P.M., Kazmier, F.J., Chesebro, J.H., Vlietstra, R.E. and Fuster, V. (1985): Systemic embolism in chronic left ventricular aneurysm: incidence and the role of anticoagulation. J. Am. Coll. Cardiol., 6, 534-538.
22. Sbarouni, E., Bradshaw, A., Andreotti, F, Tuddenham, E., Oakley, C.M. and Cleland, J.G.F. (1994): Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am. Heart J., 127, 607-612.
23. Segal, J., Stapleton, J., McClellan, J., Waller, B.F. and Harvey, W.P. (1978): Idiopathic cardiomyopathy: clinical features, prognosis and therapy. Curr. Probl. Cardiol., 31, 1-49.
24. The SPAF Investigators (1992a): Predictors of thromboembolism in atrial fibrillation. I. Clinical features of patients at risk. Ann. Intern. Med., 116, 1-5.
25. The SPAF Investigators (1992b): Predictors of thromboembolism in atrial fibrillation. II. Echocardiographic features of patients at risk. Ann. Intern. Med., 116, 6-12.
26. Stratton, J.R. (1994): Chronic left ventricular thrombi. G. Ital. Cardiol., 24, 269-279.
27. Stratton, J.R. and Nemanich, J.W. (1988): Fate of left ventricular thrombi in patients with remote myocardial infarction or idiopathic cardiomyopathy. Circulation, 78, 1388-1393.
28. Tsevat, J., Eckman, M., McNutt, R. and Pauker, S.G. (1989): Warfarin for dilated cardiomyopathy: a bloody tough pill to swallow? Med. Decis. Making, 9, 162-169.
29. Yokota, Y., Kawanishi, H., Hayakawa, M., Kumaki, T., Takarada, A., Nakanishi, O. and Fukusaki, H. (1989): Cardiac thrombus in dilated cardiomyopathy. Relationship between left ventricular pathophysyology and left ventricular thrombus. Jpn. Heart J., 30, 1-11.